Safety of combining thoracic radiation therapy with concurrent versus sequential immune checkpoint inhibition

PURPOSE: The objective of this study was to evaluate adverse events (AEs) in patients who received both immune checkpoint inhibitors and thoracic radiation therapy (RT). In particular, we compared the rate of toxicities of concurrent versus sequential delivery of thoracic RT and checkpoint inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: von Reibnitz, Donata, Chaft, Jamie E., Wu, Abraham J., Samstein, Robert, Hellmann, Matthew D., Plodkowski, Andrew J., Zhang, Zhigang, Shi, Weiji, Dick-Godfrey, Rosalind, Panchoo, Kelly H., Barker, Christopher A., Rimner, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Thoracic Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128092/
https://www.ncbi.nlm.nih.gov/pubmed/30202807
http://dx.doi.org/10.1016/j.adro.2018.05.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128092/
https://www.ncbi.nlm.nih.gov/pubmed/30202807
http://dx.doi.org/10.1016/j.adro.2018.05.001

Ejemplares similares